Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-05-20
2008-05-20
O'Sullivan, Peter (Department: 1621)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S539000, C514S542000, C514S601000, C514S602000, C514S603000, C514S604000, C514S605000, C546S293000, C560S013000, C564S086000, C564S095000
Reexamination Certificate
active
07375120
ABSTRACT:
Novel PDF inhibitors and novel methods for their use are provided.
REFERENCES:
patent: 5985900 (1999-11-01), Bender et al.
patent: 7022738 (2006-04-01), Nakamura et al.
patent: 2002322197 (2002-11-01), None
Database Caplus-Chemical Abstracts Service, Columbus, Ohio. Senju Pharmaceutical: “Peptidylhydroxamic acids and pharmaceuticals containing them”. XP002415904. Database Accession No. 2002::847789.
Christensen, IV Siegfried B.
Cummings Maxwell D.
Lee Jinhwa
Xiang Jia-Ning
Madden Laura K.
McCarthy Mary
O'Sullivan Peter
Sauermelch Loretta
SmithKline Beecham Corporation
LandOfFree
Peptide deformylase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptide deformylase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide deformylase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2813596